Internal Medicine, Gastroenterology · Atlanta, GA
NPI
1457550782
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
Emory University 1365 Clifton Rd NE, Building B, Suite 1200
Atlanta, GA, 30322
Phone (404) 778-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
242 services
Medicare patients, 2024
133
Average age 70
Drug cost, 2024
$6.2M
729 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heba N Iskandar was code 45380 (lower gi endoscopy - other), 42 times for 42 patients. In total Heba N Iskandar billed 242 services in 32 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 42 | 42 | $91.95 | $3,862 |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $135.04 | $4,051 |
| 45385 Colonoscopy - Lesion Removal | Facility | 28 | 28 | $201.45 | $5,641 |
| 43239 Upper GI Endoscopy | Facility | 27 | 27 | $82.78 | $2,235 |
| 99215 Office E&M - Established | Office | 26 | 24 | $117.24 | $3,048 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 25 | $63.59 | $1,590 |
| 99214 Office E&M - Established | Office | 17 | 17 | $82.97 | $1,411 |
By year: 2022 $33K for 284 services; 2023 $41K for 336 services; 2024 $27K for 242 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heba N Iskandar prescribed most often to Medicare patients was Stelara (Ustekinumab), with 179 prescriptions and refills. In total Heba N Iskandar wrote 729 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 179 | 220 | 24 | $4.9M |
| Omeprazole Generic | 75 | 190 | 28 | $1,461 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 63 | 63 | 62 | $813 |
| Humira(Cf) Pen Adalimumab | 56 | 56 | Under 11 | $914K |
| Mesalamine Generic | 33 | 60 | 12 | $16K |
| Pantoprazole Sodium Generic | 28 | 62 | 11 | $492 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 25 | 26 | Under 11 | $1,802 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 21 | 21 | 20 | $1,403 |
| Mercaptopurine Generic | 14 | 28 | Under 11 | $438 |
| Mesalamine Er Mesalamine | 14 | 35 | Under 11 | $7,354 |
| Ondansetron Odt Ondansetron | 13 | 13 | Under 11 | $48.28 |
| Famotidine Generic | 12 | 32 | Under 11 | $159 |
| Rinvoq Upadacitinib | 12 | 12 | Under 11 | $73K |
Brand drugs: - claims; generic drugs: 394 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heba N Iskandar $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.